BioRestorative Therapies, Inc. (BRTX)

BioRestorative Therapies Statistics

Total Valuation

BRTX has a market cap or net worth of $12.84 million. The enterprise value is $5.46 million.

Market Cap	12.84M
Enterprise Value	5.46M

Important Dates

The last earnings date was Tuesday, August 12, 2025, after market close.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

BRTX has 7.98 million shares outstanding. The number of shares has increased by 38.60% in one year.

Current Share Class	7.98M
Shares Outstanding	7.98M
Shares Change (YoY)	+38.60%
Shares Change (QoQ)	+4.59%
Owned by Insiders (%)	18.03%
Owned by Institutions (%)	3.33%
Float	5.63M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	22.18
Forward PS	5.84
PB Ratio	2.66
P/TBV Ratio	3.02
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	9.03
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.07

Current Ratio	2.07
Quick Ratio	2.01
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -137.09% and return on invested capital (ROIC) is -104.03%.

Return on Equity (ROE)	-137.09%
Return on Assets (ROA)	-66.42%
Return on Invested Capital (ROIC)	-104.03%
Return on Capital Employed (ROCE)	-270.16%
Revenue Per Employee	$55,018
Profits Per Employee	-$974,875
Employee Count	11
Asset Turnover	0.05
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +5.23% in the last 52 weeks. The beta is -0.52, so BRTX's price volatility has been lower than the market average.

Beta (5Y)	-0.52
52-Week Price Change	+5.23%
50-Day Moving Average	1.57
200-Day Moving Average	1.71
Relative Strength Index (RSI)	51.20
Average Volume (20 Days)	96,403

Short Selling Information

The latest short interest is 152,050, so 1.91% of the outstanding shares have been sold short.

Short Interest	152,050
Short Previous Month	155,518
Short % of Shares Out	1.91%
Short % of Float	2.70%
Short Ratio (days to cover)	2.42

Income Statement

In the last 12 months, BRTX had revenue of $605,200 and -$10.72 million in losses. Loss per share was -$1.29.

Revenue	605,200
Gross Profit	571,980
Operating Income	-13.09M
Pretax Income	-6.96M
Net Income	-10.72M
EBITDA	-12.89M
EBIT	-13.09M
Loss Per Share	-$1.29

Balance Sheet

The company has $7.38 million in cash and n/a in debt, giving a net cash position of $7.38 million or $0.93 per share.

Cash & Cash Equivalents	7.38M
Total Debt	n/a
Net Cash	7.38M
Net Cash Per Share	$0.93
Equity (Book Value)	4.85M
Book Value Per Share	0.61
Working Capital	3.93M

Cash Flow

In the last 12 months, operating cash flow was -$9.52 million and capital expenditures -$107,293, giving a free cash flow of -$9.63 million.

Operating Cash Flow	-9.52M
Capital Expenditures	-107,293
Free Cash Flow	-9.63M
FCF Per Share	-$1.21

Margins

Gross Margin	94.51%
Operating Margin	-2,162.91%
Pretax Margin	-1,771.91%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BRTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-38.60%
Shareholder Yield	-38.60%
Earnings Yield	-83.49%
FCF Yield	-74.95%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	256.89%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 27, 2021. It was a reverse split with a ratio of 1:4,000.

Last Split Date	Oct 27, 2021
Split Type	Reverse
Split Ratio	1:4,000

Scores

BRTX has an Altman Z-Score of -29.38 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-29.38
Piotroski F-Score	2